title: [Hematologic Malignancies/Pediatric Malignancies. Roles of Drugs Approved as New Agents and as Additional Indications for Relapse or Refractory Hematologic Malignancies].
authors.forename: Noriko
authors.initials: N
authors.lastname: Usui
mesh_terms: D000970:Antineoplastic Agents / Q000627:therapeutic use*; D002648:Child; D017277:Drug Approval; D019337:Hematologic Neoplasms / Q000188:drug therapy*; D006801:Humans; D012008:Recurrence
chemical_list: D000970:Antineoplastic Agents